BT-02 * FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA
C. S. Grasso(Oregon Health & Science University), Michelle Monje(Howard Hughes Medical Institute), Charles Keller(Children's Cancer Therapy Development Institute), Katherine E. Warren(Brigham and Women's Hospital), Marie‐Anne Debily(Inserm), Paul S. Meltzer(National Cancer Institute), Ranadip Pal(Texas Tech University), Eric C. Huang(Oregon Health & Science University), Mari Kogiso(Baylor College of Medicine), Pamelyn J. Woo(Stanford University), Matthew N. Svalina(Oregon Health & Science University), Michael J. Quist(University of California, Los Angeles), Anitha Ponnuswami(Stanford University), Paul T. Spellman(Oregon Health & Science University), Jinu Abraham(Oregon Health & Science University), Eric H. Raabe(Johns Hopkins University), Tessa Johung(Stanford University), Ludivine Le Dret(Université Paris-Sud), Maryam Fouladi(Nationwide Children's Hospital), Cynthia Hawkins(Hospital for Sick Children), Esther Hulleman(Amsterdam UMC Location VUmc), Marianne Hütt-Cabezas(NYU Langone Health), Martha Quezado(National Cancer Institute), Hua Mao(Qingdao University), Lara E. Davis(Oregon Health & Science University), Nathalène Truffaux(Université Paris-Sud), Noah Berlow(Health First), Li Liu(Shihezi University), Na Wang(Qingdao University), Yuhua Huang(Soochow University), Lin Qi(Baylor College of Medicine), Yuzhen Du(Shanghai Jiao Tong University), Yujie Tang, Wenchao Sun(Stanford University), Jacques Grill(Inserm), X.-N. Li(Baylor College of Medicine), Dannis G van Vuurden(Cancer Center Amsterdam), Shufen Chen(Huashan Hospital)
Cited by 4
Related Papers
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
|The Lancet|2014|3.2k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867